Endotoxin alters hypoxic pulmonary vasoconstriction in isolated rat lungs

Journal of Applied Physiology

Volumn 81, Issue 3, 1996, Pages 1316-1322

  Frank, Deborah U ^a   Lowson, Stuart M ^a   Roos, Christine M ^a   Rich, George F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cyclooxygenase; endothelin; endothelium derived relaxing factor; lipopolysaccharide; nitric oxide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BOSENTAN; ENDOTOXIN; INDOMETACIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HYPOXIA; ISOLATED LUNG; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0029737331     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.3.1316     Document Type: Article

References (35)

1. Beutler, B., I. W. Milsark, and A. C. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science Wash. DC 229: 869-871, 1985.
2. Brashers, V. L., M. J. Peach, and C. E. Rose. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82: 1495-1502, 1988.
3. Brigham, K. L., and B. Meyrick. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133: 913-927, 1986.
4. Chang, S.-W., J. Y. Westcott, W. C. Pickett, R. C. Murphy, and N. F. Voelkel. Endotoxin-induced lung injury in rats: role of eicosanoids. J. Appl. Physiol. 66: 2407-2418, 1989.
5. Clozel, M., V. Breu, G. A. Gray, B. Kalina, B.-M. Loffler, K. Burri, J.-M. Cassai, G. Hirth, N. Muller, W. Neidhart, and H. Ramuz. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235, 1994.
6. Crawley, D. E., S. F. Liu, P. J. Barnes, and T. W. Evans. Endothelin-3 is a potent pulmonary vasodilator in the rat. J. Appl. Physiol. 72: 1425-1431, 1992.
7. 2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ. Res. 75: 659-668, 1994.
8. Hales, C. A., L. Sonne, M. Peterson, D. Kong, M. Miller, and W. D. Watkins. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J. Clin. Invest. 68: 497-505, 1981.
9. Hampl, V., S. Archer, D. Nelson, and E. K. Weir. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J. Appl. Physiol. 75: 1748-1757, 1993.
10. Hasunuma, K., D. M. Rodman, R. F. O'Brien, and I. F. McMurtry. Endothelin-1 causes pulmonary vasodilation in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H48-H54, 1990.
11. Hutchinson, A., M. L. Ogletree, J. R. Snapper, and K. L. Brigham. Effect of endotoxemia on hypoxic pulmonary vasoconstriction in unanesthetized sheep. J. Appl. Physiol. 58: 1463-1468, 1985.
12. G-monomethyl-L-arginine does not restore loss of hypoxic pulmonary vasoconstriction induced by TNF-α. J. Appl. Physiol. 75: 618-625, 1993.
13. Kanse, S. M., K. Takahashi, H. C. Lam, A. Rees, J. B. Warren, M. Porta, P. Molinatti, M. Ghatei, and S. R. Bloom. Cytokine stimulated endothelin release from endothelial cells. Life Sci. 48: 1379-1384, 1991.
14. Koide, M., Y. Kawahara, T. Tsuda, and M. Yokoyama. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 318: 213-217, 1993.
15. Langleben, D., M. Demarchie, D. Laporta, A. H. Spanier, R. D. Schlesinger, and D. J. Stewart. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148: 1646-1650, 1993.
16. Liu, S. F., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. Lipopolysaccharide treatment in vivo induces wide-spread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196: 1208-1213, 1993.
17. Liu, S. F., D. E. Crawley, P. J. Barnes, and T. W. Evans. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143: 32-37, 1991.
18. Liu, S. F., A. Dewar, D. E. Crawley, P. J. Barnes, and T. W. Evans. Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction. J. Appl. Physiol. 72: 1044-1049, 1992.
19. Meyrick, B., L. C. Berry, and B. W. Christman. Response of cultured human pulmonary artery endothelial cells to endotoxin. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L239-L244, 1995.
20. Moncada, S., R. M. Palmer, and E. A. Higgs. Nitric oxide: pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
21. Myers, P. R., Q. Zhong, J. J. Jones, M. A. Tanner, H. R. Adams, and J. L. Parker. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H955-H961, 1995.
22. Plotkime, M., N. el Bouchi, M. Allix, C. Capdeville, V. Bouchon, and R. G. Boulu. Effect of indomethacin on the coupling of cerebral blood flow to brain metabolism. J. Pharmacol. Paris 17: 286-294, 1986.
23. Reeves, J. T., and R. F. Grover. Blockade of acute hypoxic pulmonary hypertension by endotoxin. J. Appl. Physiol. 36: 328-332, 1974.
24. Shaul, P. W., B. Kinane, M. A. Farrar, L. M. Buja, and R. R. Magness. Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat. J. Clin. Invest. 88: 447-455, 1991.
25. Shirakami, G., K. Nakao, Y. Saito, T. Magaribuchi, M. Jongasaki, M. Mukoyama, H. Arai, K. Hosoda, S. Suga, Y. Ogawa, T. Yamada, K. Mori, and H. Imura. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci. 48: 969-976, 1991.
26. Simmet, T., S. Prize, K. I. Thelen, and B. A. Peskar. Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats. Eur. J. Pharmacol. 211: 319-322, 1992.
27. Stevens, T., P. L. Janssen, and A. Tucker. Acute and long-term TNF-α administration increases pulmonary vascular reactivity in isolated rat lungs. J. Appl. Physiol. 73: 708-712, 1992.
28. Stevens, T., K. Morris, I. F. McMurtry, M. Zamora, and A. Tucker. Pulmonary and systemic vascular responsiveness to TNF-α in conscious rats. J. Appl. Physiol. 74: 1905-1910, 1993.
29. Suttorp, N., C. Galanos, and H. Neuhof. Endotoxin alters arachidonate metabolism in pulmonary endothelial cells. Am. J. Physiol. 253 (Cell Physiol. 22): C384-C390, 1987.
30. Thiessen, J. L., H. M. Loick, B. B. Curry, L. D. Traber, D. N. Herndon, and D. L. Traber. Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J. Appl. Physiol. 70: 2120-2125, 1991.
31. Tracey, K. J., F. L. Stephen, and A. Cerami. Cachectin/TNF-α in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138: 1377-1379, 1988.
32. Weir, E. K., J. Mlczoch, J. T. Reeves, and R. F. Grover. Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J. Lab. Clin. Med. 88: 975-983, 1976.
33. Xie, J., Y. Wang, H. Lippton, B. Cai, S. Nelson, J. Kolls, W. R. Summer, and S. S. Greenberg. Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide. Am. Rev. Respir. Dis. 148: 627-636, 1993.
34. Yoshizumi, M., M. A. Perrella, J. C. Burnett, and M.-E. Lee. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.
35. Zelenkov, P., T. McLoughlin, and R. A. Johns. Endotoxin enhances hypoxic constriction of rat aorta and pulmonary artery through induction of EDRF/NO synthase. Am. J. Physiol. 265 (Lung Mol. Cell. Physiol. 9): L346-L354, 1993.